Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 3
2012 1
2015 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Assessment of fungal bioaerosols and particulate matter characteristics in indoor and outdoor air of veterinary clinics.
Mosalaei S, Amiri H, Rafiee A, Abbasi A, Baghani AN, Hoseini M. Mosalaei S, et al. J Environ Health Sci Eng. 2021 Aug 28;19(2):1773-1780. doi: 10.1007/s40201-021-00732-8. eCollection 2021 Dec. J Environ Health Sci Eng. 2021. PMID: 34900306 Free PMC article.
The concentrations of fungal bio-aerosols ranged from 8.05 CFU/m (3) in the outdoor air of clinic B to 47.21 CFU/m (3) in the operating room of clinic A. ...The corresponding values for PM(10) ranged from 114.40 mug/m (3) in the operating room of clinic C to …
The concentrations of fungal bio-aerosols ranged from 8.05 CFU/m (3) in the outdoor air of clinic B to 47.21 CFU/m (3) in the …
Efficacy and safety of concurrent chemoradiation with weekly cisplatin ± low-dose celecoxib in locally advanced undifferentiated nasopharyngeal carcinoma: a phase II-III clinical trial.
Mohammadianpanah M, Razmjou-Ghalaei S, Shafizad A, Ashouri-Taziani Y, Khademi B, Ahmadloo N, Ansari M, Omidvari S, Mosalaei A, Mosleh-Shirazi MA. Mohammadianpanah M, et al. J Cancer Res Ther. 2011 Oct-Dec;7(4):442-7. doi: 10.4103/0973-1482.92013. J Cancer Res Ther. 2011. PMID: 22269407 Free article. Clinical Trial.
The patients were assigned to receive 7 weeks concurrent chemoradiation (70 Gy) with weekly cisplatin 30 mg/m 2 with either celecoxib 100 mg twice daily, (study group, n = 26) or placebo (control group, n = 27) followed by adjuvant combined chemotherapy with cisplatin 70 m …
The patients were assigned to receive 7 weeks concurrent chemoradiation (70 Gy) with weekly cisplatin 30 mg/m 2 with either celecoxib …
The efficacy and safety of neoadjuvant chemotherapy +/- letrozole in postmenopausal women with locally advanced breast cancer: a randomized phase III clinical trial.
Mohammadianpanah M, Ashouri Y, Hoseini S, Amadloo N, Talei A, Tahmasebi S, Nasrolahi H, Mosalaei A, Omidvari S, Ansari M, Mosleh-Shirazi MA. Mohammadianpanah M, et al. Breast Cancer Res Treat. 2012 Apr;132(3):853-61. doi: 10.1007/s10549-011-1814-6. Epub 2011 Oct 16. Breast Cancer Res Treat. 2012. PMID: 22002564 Clinical Trial.
Chemotherapy consisted of a median 4 (range 3-5) cycles of intravenous 5-fluorouracil 600 mg/m(2), doxorubicin 60 mg/m(2), and cyclophosphamide 600 mg/m(2), every three weeks. ...
Chemotherapy consisted of a median 4 (range 3-5) cycles of intravenous 5-fluorouracil 600 mg/m(2), doxorubicin 60 mg/m(2), and …
A Phase II Study of Docetaxel, Cisplatin and 5- Fluorouracil (TPF) In Patients with Locally Advanced Head and Neck Carcinomas.
Ansari M, Omidvari S, Mosalaei A, Ahmadloo N, Mosleh-Shirazi MA, Mohammadianpanah M. Ansari M, et al. Iran Red Crescent Med J. 2011 Mar;13(3):187-91. Epub 2011 Mar 1. Iran Red Crescent Med J. 2011. PMID: 22737461 Free PMC article.
All patients received three cycles of induction chemotherapy with docetaxel (75 mg/m(2)), cisplatin (40 mg/m(2)) (days 1-2), and 5-FU (500 mg/m(2), days 1-3), repeated every 21 days. Following induction chemotherapy, all patients underwent concurrent chemorad …
All patients received three cycles of induction chemotherapy with docetaxel (75 mg/m(2)), cisplatin (40 mg/m(2)) (days 1-2), a …
Efficacy and Safety of Low-Dose-Rate Endorectal Brachytherapy as a Boost to Neoadjuvant Chemoradiation in the Treatment of Locally Advanced Distal Rectal Cancer: A Phase-II Clinical Trial.
Omidvari S, Zohourinia S, Ansari M, Ghahramani L, Zare-Bandamiri M, Mosalaei A, Ahmadloo N, Pourahmad S, Nasrolahi H, Hamedi SH, Mohammadianpanah M. Omidvari S, et al. Ann Coloproctol. 2015 Aug;31(4):123-30. doi: 10.3393/ac.2015.31.4.123. Epub 2015 Aug 31. Ann Coloproctol. 2015. PMID: 26361613 Free PMC article.
All the patients were treated with LDRBT (15 Gy in 3 fractions) and concurrent chemoradiation (45-50.4 Gy). Concurrent chemotherapy consisted of oxaliplatin 130 mg/m(2) intravenously on day 1 plus oral capecitabine 825 mg/m(2) twice daily during LDRBT and EBRT. ...
All the patients were treated with LDRBT (15 Gy in 3 fractions) and concurrent chemoradiation (45-50.4 Gy). Concurrent chemotherapy consiste …